Assessment of individuals’ knowledge in the most risky age group for prostate cancer about risk factors and the importance of early screening
DOI:
https://doi.org/10.33687/ricosbiol.03.07.65Keywords:
knowledge, prostate cancer, PSA, awareness, informationAbstract
Abstract
Notably, one of the most prevalent male cancers is prostate cancer (PCa) which considered the second leading reason of globally cancer-associated deaths among males. This study investigated the knowledge about risk factors especially age, and the importance of early screening of PCa among male participants. A cross-sectional questionnaire study was carried on 306 males of whom the majority was between 50–59 years old (41.5%) from January 2025 to March 2025. Around 63.4% of participants were working. The urban participants constitute 78.1%. Most of participants are of university education level (34.3%). Bivariate data were analyzed and relations were deemed significant if the p-value was ≤ 0.05. The obtained results revealed that 20.9% of participants or their relatives have suffered from a prostate condition. The prostatic enlargement was the most condition reported among the concerned participants (50.0%). On other side, 4.6% had prostate cancer. Family history of prostate conditions was reported in 14.7%. Notably, 94.4% of the participants had an inadequate level of knowledge about both the PSA test and prostate cancer and 96.4% had a negative attitude towards them. The main information source was social media and internet for 47.4% of participants, followed by healthcare providers (25.8%). It was concluded that there was a poor level of knowledge and negative attitude towards screening for prostate cancer and its risk factors among males. This could be attributed to the lack of education and shortage of healthcare providers to focus on the risks of prostate cancer.
Downloads
References
Atulomah N.O., Olanrewaju M.F., Amosu A. and Adedeji O. (2010). Level of awareness, perception and screening behavior regarding prostate cancer among men in a rural community of Ikenne local government area, Nigeria. Prim Prev Insights. 2,11–20.
Benurugo G., Munyambaraga E., Chironda G. and Bisanukuri E. (2020). Awareness on prostate cancer and screening practices among men attending outpatient at a referral hospital in Kigali, Rwanda:A quantitative study. Int J Afr Nurs Sci., 13,100241. doi:10.1016/j.ijans. 2020.100241.
Bergengren O., Pekala K.R., Matsoukas K., Fainberg J., Mungovan S.F., Bratt O., Bray F., Brawley O., Luckenbaugh A.N., Mucci L., Morgan T.M. and Carlsson S.V. (2023). Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. Eur Urol. 2023 Aug; 84(2),191-206. doi: 10.1016/j.eururo.2023.04.021.
Bray F., Laversanne M. and Sung H. et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74, 229–263
Cornford P., Van Den Bergh R.C.N. and Briers E. et al., (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86, 148–163.
Ferlay E.M., Lam F., Colombet M., Mery L., Pineros M. and Znaor A. (2020). Global cancer observatory: Cancer today. Lyon, France. International Agency for Research on Cancer.
Force U.S.P.S.T., Grossman D.C. and Curry S.J. et al. (2018). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA, 319, 1901–13.
Gift S., Nancy K. and Victor M. (2020). Assessment of knowledge, practice and attitude towards prostate cancer screening among male patients aged 40 years and above at Kitwe Teaching Hospital, Zambia. Afr J Urol., 26, 70. doi:10.1186/s12301-020-00067-0.
Hilscher M., Røder A., Helgstrand J.T., Klemann N., Brasso K., Vickers A.J. and Stroomberg H.V. (2022). Risk of prostate cancer and death after benign transurethral resection of the prostate-A 20-year population-based analysis. Cancer, 128(20), 3674-3680. doi: 10.1002/cncr.34407.
Littrup, P. J., Goodman, A. C., and Mettlin, C. J. (1993). The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. CA: a cancer journal for clinicians, 43(3), 134–149. https://doi.org/10.3322/canjclin.43.3.134
Morlando M., Pelullo C.P. and Di Giuseppe G. (2017). Prostate cancer screening:Knowledge, attitudes and practices in a sample of men in Italy. A survey. PLoS One, 12:e0186332. doi: 10.1371/journal.pone.0186332.
Necku J.G., Anaba E.A. and Abuosi A.A. (2019). Prostate cancer awareness and attitude toward early detection among male soldiers in Ghana: A cross-sectional study. Afr. J. Urol., 25, 5. doi:10.1186/s12301-019-0004-3.
Nelson W.G., Antonarakis E.S., Carter H.B., DeMarzo A.M. and DeWeese TL. (2020). Chapter 81: Prostate Cancer. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier.
Nyame Y.A., Gulati R. and Heijnsdijk E.A.M., et al. )2021). The impact of intensifying prostate cancer screening in Black men: a model-based analysis. J. Natl. Cancer Inst., 113:1336–42.
Oladimeji O., Bidemi Y.O., Olufisayo J-AY, Sola A.O. (2010). Prostate cancer awareness, knowledge, and screening practices among older men in Oyo State, Nigeria. Int. Q Community Health Educ., 30:271–86. doi: 10.2190/IQ.30.3.g.
Orio, P. F., Atalar, B., and Eren, M. F. (2024). Prostate Cancer Awareness in the Middle East: A Cross-Sectional International Study. JCO global oncology, 10, e2400171. https://doi.org/10.1200/GO.24.00171
Sayan, M., Eren, A. A., Tuac, Y., Langoe, A., Alali, B., Aynaci, O., Mohammadipour, S., Vahedi, F., Daneshmand, B., Abbas, W., Hawsawi, Y., Nader, T., Joseph, J., Wahby, R., Ozgenc, I., Mula-Hussain, L., Moningi, S., Shan J., Liu Z. and Geng X et al. (2022) The influence of age on prostate cancer screening index. J. Clin. Lab. Anal. 36,e24098
Siegel R.L., Miller K.D., Fuchs H.E. and Jemal A. (2022). Cancer statistics. CA. Cancer J. Clin., 72, 7–33.
Sun, D. Q., Lei, L., Cai, Y., Li, H., Cao, M. M., He, S. Y., Yu, X. Y., Peng, J., & Chen, W. Q. (2021). Zhonghua zhong liu za zhi [Chinese journal of oncology], 43(4), 443–448. https://doi.org/10.3760/cma.j.cn112152-20200610-00544
Sung H., Ferlay J. and Siegel R.L. et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 71, 209–249.
Published
Data Availability Statement
Ricos Biology Journal
Issue
Section
Categories
License
Copyright (c) 2025 Israa Abdul Wahhab Ati
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
